News | Cardio-oncology

Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented recently at EuroEcho-Imaging 2018, Dec. 5-8 in Milan, Italy.

Home January 03, 2019
Home
News | Cath Lab

Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be given to Julio Palmaz, Leonard Pinchuk, John Simpson, Richard Schatz and Paul Yock for innovations leading to the widespread adoption of percutaneous coronary intervention (PCI), also known as angioplasty with stent or coronary angioplasty. The $500,000 biennial prize, which recognizes a bioengineering achievement that significantly improves the human condition, cites PCI for “seminal contributions to coronary angioplasty, enabling minimally invasive treatment of advanced coronary artery disease.”

Home January 03, 2019
Home
360 Photos | 360 View Photos

This is a 360 degree photo during a chronic total occlusion (CTO) procedure at the University of Colorado Hospital with ...

Home January 03, 2019
Home
Videos | Cath Lab

This is a walk through inside one of the cardiac hybrid cath labs at the University of Colorado Hospital in Aurora ...

Home January 03, 2019
Home
Videos | EP Lab

This is a quick video tour of one of the dedicated electrophysiology (EP) labs at the University of Colorado Hospital ...

Home January 03, 2019
Home
Videos | Cath Lab

This is the newest cardiac cath lab at the University of Colorado Hospital in Aurora, Colorado. Construction was ...

Home January 03, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for its large-scale, second generation Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo], allowing for broad commercial launch in the United States.

Home January 02, 2019
Home
News

Boston Scientific Corp. exercised its option to acquire the remaining shares of Millipede Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study. The acquisition will expand the Boston Scientific Structural Heart portfolio to include the Iris Transcatheter Annuloplasty Ring System, which is in development for the treatment of patients with severe mitral regurgitation (MR) who are not able to tolerate open-heart surgery.

Home January 02, 2019
Home
Technology | Heart Valve Technology

Edwards Lifesciences Corp. announced that the Sapien 3 Ultra system has received U.S. Food and Drug Administration (FDA) approval for transcatheter aortic valve replacement (TAVR) in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.

Home January 02, 2019
Home
News | Blood Testing

Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as said products have been found to inaccurately report high INR test results. This recall only includes CoaguChek test strips distributed directly to U.S. consumers by Terrific Care LLC. / Medex Supply Dist Inc via its website/phone calls/facsimal of all catalog/REF numbers that do not end in 160.

Home December 28, 2018
Home
News | Hypertension

African-American men participating in a blood pressure reduction program implemented in barbershops continued to have significant improvements in their blood pressure in a twelve-month follow-up study. The research was published in the American Heart Association journal Circulation.

Home December 27, 2018
Home
News | Cath Lab

Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if scans came back clear, with no signs of blocked coronary arteries. Some of these cases are caused by a little-known phenomenon called coronary slow flow. Now, researchers at Jefferson (Philadelphia University + Thomas Jefferson University), have demonstrated for the first time a simple technique to effectively treat this under-recognized condition. They published their findings in the Journal of Invasive Cardiology on Dec. 15.

Home December 27, 2018
Home
News | Cardio-oncology

Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis, according to a report published online in Blood. The study compared this group with similar adults who do not have cancer during the same period. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.

Home December 21, 2018
Home
News | Population Health

Tens of thousands of people across North Carolina are at high risk of developing cardiovascular disease that had not been identified previously, according to a new study published in Journal of the American Medical Informatics Association. The study team, composed of researchers at the University of North Carolina (UNC) School of Medicine and the UNC Gillings School of Global Public Health, created a statewide network of healthcare professionals in urban, suburban, and rural areas who work in small primary care practices and used existing electronic health records to identify at-risk individuals. Primary care doctors across the state then used this analysis to proactively engage patients to reduce their risk.

Home December 21, 2018
Home
Technology | FFR Technologies

CathWorks announced that its FFRangio System received U.S. Food and Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive fraction flow reserve (FFR) wire in a blinded comparative study, FAST-FFR. The results of the FAST-FFR pivotal study were used to establish substantial equivalence of the FFRangio system.

Home December 21, 2018
Home
Subscribe Now